0001225208-16-028376.txt : 20160226 0001225208-16-028376.hdr.sgml : 20160226 20160226150506 ACCESSION NUMBER: 0001225208-16-028376 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160224 FILED AS OF DATE: 20160226 DATE AS OF CHANGE: 20160226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CANGIALOSI LORETTA V CENTRAL INDEX KEY: 0001174449 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 161460918 MAIL ADDRESS: STREET 1: PFIZER INC. ATTN. CORPORATE SECRETARY STREET 2: 235 EAST 42ND ST. CITY: NEW YORK STATE: NY ZIP: 10017 4 1 doc4.xml X0306 4 2016-02-24 0000078003 PFIZER INC PFE 0001174449 CANGIALOSI LORETTA V PFIZER INC.-CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 1 Sr. Vice President, Controller Common Stock 2016-02-24 4 M 0 34171.0000 18.9000 A 210943.0000 D Common Stock 2016-02-24 4 F 0 6713.0000 30.0200 D 204230.0000 D Common Stock 2016-02-24 4 F 0 16124.0000 29.6700 D 188106.0000 D Common Stock 2016-02-25 4 A 0 4992.0000 0.0000 A 193098.0000 D Common Stock 811.0000 I By Rule 16b-3 Plan Stock Appreciation Rights 18.9000 2016-02-24 4 M 0 34171.0000 0.0000 D 2016-02-24 2016-02-24 Common Stock 34171.0000 0.0000 D Stock Appreciation Rights 30.5900 2016-02-25 4 A 0 25862.0000 0.0000 A 2021-02-25 2021-02-25 Common Stock 25862.0000 25862.0000 D Stock Appreciation Rights 30.5900 2016-02-25 4 A 0 23112.0000 0.0000 A 2023-02-25 2023-02-25 Common Stock 23112.0000 23112.0000 D The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Susan E. Grant, by power of atty., for Loretta V. Cangialosi 2016-02-26